TMCnet News

Global $4.85 Billion Intra-Uterine Contraceptive Devices (IUCD) Market to 2024 - Research and Markets

[October 20, 2017]

Global $4.85 Billion Intra-Uterine Contraceptive Devices (IUCD) Market to 2024 - Research and Markets

The "Global IUCD Market Analysis, Companies Profiles, Size, Share, Growth, Trends and Forecast to 2024" report has been added to Research and Markets' offering.

In this region, global intra-uterine contraceptive devices market is projected to reach USD 4,851.2 million by 2024 from USD 3,684.1 million in 2016, at a CAGR of 3.5% in the forecast period 2017 to 2024.

The global intra-uterine contraceptive devices market is segmented on the basis of product type, end user, and geography.

The global intra-uterine contraceptive devices market is segmented into 2 product types, namely copper IUCD and hormonal IUCD.

On the basis of end users the market is segmented into hospitals, gynaecology clinics, and community healthcare. In 2017, the hospital segment is expected to dominate the market and is expected to continue this trend till 2024.

Market Overview

Drivers

Rising Cases of Chronic Diseases
Rising Demand of Self-Injection Devices
Growth of Biologics Market
Technological Advancements and Innovations in Drug Delivery Market

Restraints

Needlestick Injuries and Infections
High Cost of Development
Strict Regulatory Framework

Opportunity

Increasing Demand for Generic and Biosimilar Drugs
Generics
Biosimilars
Increasing Demand for Contraceptive Injectables
Increasing Demand for Self-Administration of Drugs

Challeges

Alternative Route of Drug Administration
Product Recall
Stability of Products
Sterility of Injections

Global intra-uterine contraceptive devices (IUCD) market competition by top players including:

Bayer AG dominated the IUCD market accounting largest market share followed by Teva Pharmaceuticals Industries Ltd., and Mona Lisa N.V. along with others such as include: